Method for killing colorectal cancer cells

US12220430B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12220430-B2
Application numberUS-202318301505-A
CountryUS
Kind codeB2
Filing dateApr 17, 2023
Priority dateApr 15, 2021
Publication dateFeb 11, 2025
Grant dateFeb 11, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Silver and titanium oxide nanoparticles produced with Fomes fomentarius or Fomitopsis pinicola aqueous extracts and methods for treating bacterial infections or cancer using them.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of making TiO 2 nanoparticles, comprising: drying a Fomitopsis pinicola sample to form a F. pinicola powder, mixing the F. pinicola powder with water to form a F. pinicola precursor, sonicating the F. pinicola precursor then centrifuging to obtain a F. pinicola extract; reacting the F. pinicola extract with titanium isopropoxide to form the TiO 2 nanoparticles; and isolating and drying the TiO 2 nanoparticles, wherein upon contacting the TiO 2 nanoparticles with colorectal cancer cells a cell viability of the colorectal cancer cells is reduced to 20% of a cell viability of a control group of colorectal cancer cells not contacted with the TiO 2 nanoparticles, wherein an amount of the TiO 2 nanoparticles in the contacting with the colorectal cancer cells is 0.5 μg per milliliter of a cell culture of the colorectal cancer cells, wherein upon contacting the TiO 2 nanoparticles with the colorectal cancer cells a cell nuclei of the colorectal cancer cells undergo nuclear condensation thereby killing a majority of the colorectal cancer cells, wherein the TiO 2 nanoparticles contain components of the F. pinicola as evident by Fourier transform infrared (FT-IR) spectroscopy absorption peaks at 1414 cm −1 , and 1000 cm −1 corresponding to aliphatic C—N, and aromatic C═N bands, respectively, wherein the TiO 2 nanoparticles have a further FT-IR spectroscopy absorption peak at 3439 cm −1 corresponding to —OH, and wherein the TiO 2 nanoparticles have a broadest dimension ranging from 80 to 120 nm. 2. The method of claim 1 , wherein the TiO 2 nanoparticles are agglomerated. 3. The method of claim 1 , wherein the TiO 2 nanoparticles are in a rutile phase and an anatase phase. 4. The method of claim 1 , wherein in the reacting a ratio of the F. pinicola extract to the titanium isopropoxide by volume is 1:10, and wherein the titanium isopropoxide has a 1 millimolar concentration in water. 5. The method of claim 4 , wherein the colorectal cancer cells are HCT-116 cells.

Assignees

Inventors

Classifications

  • Basidiomycota, e.g. Cryptococcus · CPC title

  • Silver; Compounds thereof · CPC title

  • Oxides; Hydroxides · CPC title

  • Nanocapsules; {Nanoparticles; (nanotubes A61K9/0092; polymeric micelles A61K9/1075; polymersomes A61K9/1273; pure drug nanoparticles A61K9/14; drug nanoparticles with adsorbed surface modifiers A61K9/141; conjugates, e.g. between drug and non-active nanoparticles, A61K47/50; preparations for in vivo diagnosis A61K49/00; with radioactive substances A61K51/00)} · CPC title

  • Processes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12220430B2 cover?
Silver and titanium oxide nanoparticles produced with Fomes fomentarius or Fomitopsis pinicola aqueous extracts and methods for treating bacterial infections or cancer using them.
Who is the assignee on this patent?
Univ Imam Abdulrahman Bin Faisal
What technology area does this patent fall under?
Primary CPC classification A61K33/24. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).